Skip to main content
Orchid Ventures, Inc. logo

Orchid Ventures, Inc. — Investor Relations & Filings

Ticker · ORVRF ISIN · CA68573L1076 LEI · 8945000TK5RMLOVX4I24 CSE Manufacturing
Filings indexed 252 across all filing types
Latest filing 2020-12-17 Capital/Financing Update
Country CA Canada
Listing CSE ORVRF

About Orchid Ventures, Inc.

https://www.orchidessentials.com

Orchid Ventures, Inc. is a cannabis innovation company engaged in the design, development, manufacturing, branding, and distribution of branded cannabis vape products and proprietary hardware delivery systems. The company markets the "Orchid Essentials" brand, which includes comprehensive product lines featuring both tetrahydrocannabinol (THC) and cannabidiol (CBD) formulations. A key operational focus is the development of advanced delivery technology. This is executed through its subsidiary, PurTec Delivery Systems, which designs and sells proprietary, patent-pending hardware solutions to the cannabis and CBD sectors throughout North America. The company emphasizes clean product standards and mass-market appeal.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Amended and Restated Pricing Supplement' and references a 'short form base shelf prospectus' and a 'Prospectus Supplement.' It details terms of a specific note securities offering, including maturity dates, call thresholds, redemption payments, and risk factors. The content is focused on the terms and conditions of a securities offering, typical of a pricing supplement or prospectus document related to capital markets and financing activities. There is no indication of it being an annual report, earnings release, management discussion, or any other category. The document is not a brief announcement but a detailed supplement to a prospectus, which fits the category of Capital/Financing Update (CAP).
2020-12-17 English
News release - English.pdf
Regulatory Filings
2020-12-14 English
News release - English.pdf
Management Reports Classification · 95% confidence The document is a shareholder update letter from the CEO of Orchid Ventures, discussing delays in the annual audit for Fiscal 2020 and plans to release Q1 2021 earnings. It mentions the audit is not yet completed and the company intends to file the annual financials by December 28, 2020. The letter also discusses business strategy, operational challenges, and future plans. There are no actual financial statements or detailed financial data included in this document. It is primarily a management communication providing an update on audit status and business outlook, not a full annual report or interim report. The document is about 9,522 characters, which is substantial but does not contain the full audited financials or comprehensive financial data. Therefore, it is best classified as a Management Reports (MDA) document, as it contains management's explanation and update on financial results and business trends, but not the full report itself.
2020-12-09 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing new retail accounts for Orchid Ventures and providing an update on the status of their annual audit. It mentions that the annual financial filings were not filed on time due to the COVID-19 pandemic and that the auditors need more time to complete the audit. The company expects to complete the filings before December 28, 2020. The document does not contain the actual annual report or financial statements but rather an update on the audit process and filing delay. It is a regulatory announcement about the status of the annual audit and filings, not the audit report itself or the annual report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and update on filing status.
2020-11-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a sales and distribution agreement between Orchid Ventures and Landrace, LLC, focusing on business expansion and partnership details. It contains no financial statements, regulatory filings, voting results, or management changes. It is a corporate announcement about a commercial agreement and market expansion, not a financial report, regulatory filing, or governance document. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2020-11-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that PurTec vaporizer cartridges are now available in four Canadian provinces. It discusses business operations, product launches, and challenges related to COVID-19. It mentions that the annual financial filings were not filed on time due to the pandemic and that the auditors need more time to complete the audit. The company is in default status under National Policy 12-203 and intends to satisfy filing requirements by December 28, 2020. There is no actual financial data or detailed financial statements included in the document. The document is primarily an announcement about business developments and a status update on delayed filings, not the filings themselves. It is not a full annual report or audit report, nor is it a regulatory certification or officer attestation. Given the nature of the content and the absence of substantive financial data, the document best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements and compliance updates that do not fit other categories.
2020-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.